P. Saiag, R. Gutzmer, P. A. Ascierto, M. Maio, J.-J. Grob, et al.. Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).
Annals of Oncology, Elsevier, 2016, 27, pp.1947 - 1953.
⟨10.1093/annonc/mdw291⟩.
⟨inserm-01407384⟩